Figure 11. Association of FAM20C and TBX1 expression with immunotherapy efficiency. (A) Survival analysis of the indicative genes in the immunotherapy of BLCA (anti-PD-1) and (B) urothelial carcinomas (anti-PD-L1) through the Kaplan-Meier plotter platform.